Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yepeng Luan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Mini Reviews in Medicinal Chemistry|December 16, 2006
The function of the selective inhibitors of cyclooxygenase 2Yepeng Luan, Wenfang Xu
Current Medicinal Chemistry|March 10, 2007
The structure and main functions of aminopeptidase NYepeng Luan, Wenfang Xu
Mini Reviews in Medicinal Chemistry|September 28, 2016
Tip60: Main Functions and Its InhibitorsXiaoli Zhang, Jiyong Wu, Yepeng Luan
Current Medicinal Chemistry|August 18, 2019
Small Molecular Gemcitabine Prodrugs for Cancer TherapyHe Miao, Xuehong Chen, Yepeng Luan
Chembiochem : a European Journal of Chemical Biology|October 13, 2015
Integration of Bioorthogonal Probes and Q-FRET for the Detection of Histone Acetyltransferase ActivityZhen Han, Yepeng Luan, Yujun George Zheng
Drug Discoveries & Therapeutics|December 18, 2022
WRQ-2, a gemcitabine prodrug, reverses gemcitabine resistance caused by hENT1 inhibitionRuquan Wang, Yongliang Li, Jianjun Gao, et al.
Mini Reviews in Medicinal Chemistry|July 18, 2023
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer TherapyJing Nie, Huina Wu, Yepeng Luan, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Development of VER-50589 analogs as novel Hsp90 inhibitorsXixi Fang, Jinhong Feng, Kewei Wang, et al.
Drug Discoveries & Therapeutics|May 13, 2016
Discovery of N-hydroxy-4-(1H-indol-3-yl)butanamide as a histone deacetylase inhibitorJiang Bian, Yepeng Luan, Chunbo Wang, et al.
Current Medicinal Chemistry|August 31, 2022
Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer TherapyJiyong Wu, Jing Nie, Yepeng Luan, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Mini Reviews in Medicinal Chemistry|December 16, 2006
The function of the selective inhibitors of cyclooxygenase 2Yepeng Luan, Wenfang Xu
Current Medicinal Chemistry|March 10, 2007
The structure and main functions of aminopeptidase NYepeng Luan, Wenfang Xu
Mini Reviews in Medicinal Chemistry|September 28, 2016
Tip60: Main Functions and Its InhibitorsXiaoli Zhang, Jiyong Wu, Yepeng Luan
Current Medicinal Chemistry|August 18, 2019
Small Molecular Gemcitabine Prodrugs for Cancer TherapyHe Miao, Xuehong Chen, Yepeng Luan
Chembiochem : a European Journal of Chemical Biology|October 13, 2015
Integration of Bioorthogonal Probes and Q-FRET for the Detection of Histone Acetyltransferase ActivityZhen Han, Yepeng Luan, Yujun George Zheng
Drug Discoveries & Therapeutics|December 18, 2022
WRQ-2, a gemcitabine prodrug, reverses gemcitabine resistance caused by hENT1 inhibitionRuquan Wang, Yongliang Li, Jianjun Gao, et al.
Mini Reviews in Medicinal Chemistry|July 18, 2023
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer TherapyJing Nie, Huina Wu, Yepeng Luan, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2023
Development of VER-50589 analogs as novel Hsp90 inhibitorsXixi Fang, Jinhong Feng, Kewei Wang, et al.
Drug Discoveries & Therapeutics|May 13, 2016
Discovery of N-hydroxy-4-(1H-indol-3-yl)butanamide as a histone deacetylase inhibitorJiang Bian, Yepeng Luan, Chunbo Wang, et al.
Current Medicinal Chemistry|August 31, 2022
Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer TherapyJiyong Wu, Jing Nie, Yepeng Luan, et al.
Pageof 4